A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol
doi: 10.1210/jc.2017-02566 52 SchmidHBrueTColaoAGadelhaMRShimonIKapurKet al
BPC-157 appears to promote healing by enhancing angiogenesis, accelerating cellular repair, and reducing inflammation in injured tissues
Novo was first in the market,got CMS Medicare approval with Narrow Pipeline of Drugs only on Weight loss & Diabetes (Front runner Semaglutide) Lilly has better Efficacy Drug(Tirzepatide & Pipeline drugs) for Wt loss/Diabetes,Longer IP Patent Runway till mid 2030s with better Growth Penetration With Wider Pipeline of Pharma drugs including Oncology/ Neurology/ Immunology/ Inflammation,Urology- Erectile Dysfunction,Osteoporosis in Men and Women and afford to run the price war with Novo and wipeout their Business Eli Lilly is winning hands down
Knowing how menopause affects your health can help you navigate this new chapter with more confidenceand less frustration
In UK clinical practice, combining Trulicity (dulaglutide) and Januvia (sitagliptin) is generally not recommended according to NICE guidance